Literature DB >> 23006039

The effect of restrictive bariatric surgery on urolithiasis.

Tony Chen1, Elana Godebu, Santiago Horgan, Hossein S Mirheydar, Roger L Sur.   

Abstract

BACKGROUND AND
PURPOSE: Roux-en-Y gastric bypass (RYGB) surgery, a mixed malabsorptive/restrictive procedure, is associated with enteric hyperoxaluria and an increased risk of kidney stones. The incidence of nephrolithiasis after purely restrictive bariatric procedures such as adjustable gastric banding or sleeve gastrectomy has not been well described. We aim to analyze the incidence of kidney stones in patients who undergo either adjustable gastric banding or sleeve gastrectomy. PATIENTS AND METHODS: In a retrospective study, we analyzed a pool of 332 patients who underwent adjustable gastric banding and 85 patients who underwent sleeve gastrectomy at the University of California, San Diego Center for the Treatment for Obesity within a 54-month period (September 2006 to February 2011). The primary outcomes of urinary calculus diagnosis and surgical treatment were investigated using manual chart review and International Classification of Diseases and Related Health Problems-9 code electronic search.
RESULTS: Within the adjustable gastric banding cohort, we found a person-time incidence rate of 3.40 stone diagnoses per 1000 person-years. Within the sleeve gastrectomy cohort, we found a person-time incidence rate of 5.25 stone diagnoses per 1000 person-years.
CONCLUSIONS: Questions remain whether purely restrictive bariatric procedures such as sleeve gastrectomy or adjustable gastric banding avoid the risk of kidney stones. Our study demonstrates a very low incidence of kidney stones after restrictive bariatric procedures, although larger sample sizes, longer follow-up times, and controlled prospective studies are necessary to validate this finding.

Entities:  

Mesh:

Year:  2012        PMID: 23006039     DOI: 10.1089/end.2012.0408

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  17 in total

1.  Update on the evaluation of repeated stone formers.

Authors:  Adam O Kadlec; Thomas M Turk
Journal:  Curr Urol Rep       Date:  2013-12       Impact factor: 3.092

Review 2.  Kidney stone risk following modern bariatric surgery.

Authors:  Ricardo D Gonzalez; Benjamin K Canales
Journal:  Curr Urol Rep       Date:  2014-05       Impact factor: 3.092

3.  Long-term incidence of symptomatic urolithiasis post-bariatric surgery.

Authors:  Nicholas Haddad; Patrick Scheffler; Mohamed A Elkoushy; Olivier Court; Nicolas V Christou; Ross E Andersen; Sero Andonian
Journal:  Can Urol Assoc J       Date:  2014-09       Impact factor: 1.862

Review 4.  Stone formation and management after bariatric surgery.

Authors:  Sarah Tarplin; Vishnu Ganesan; Manoj Monga
Journal:  Nat Rev Urol       Date:  2015-04-07       Impact factor: 14.432

Review 5.  Kidney Stones After Bariatric Surgery: Risk Assessment and Mitigation.

Authors:  Pedro Mario Espino-Grosso; Benjamin Kirk Canales
Journal:  Bariatr Surg Pract Patient Care       Date:  2017-03-01       Impact factor: 0.607

Review 6.  Obesity-related immune responses and their impact on surgical outcomes.

Authors:  M Quante; A Dietrich; A ElKhal; S G Tullius
Journal:  Int J Obes (Lond)       Date:  2015-02-20       Impact factor: 5.095

Review 7.  Kidney stone incidence and metabolic urinary changes after modern bariatric surgery: review of clinical studies, experimental models, and prevention strategies.

Authors:  Benjamin K Canales; Marguerite Hatch
Journal:  Surg Obes Relat Dis       Date:  2014-04-15       Impact factor: 4.734

8.  Safety analysis of primary bariatric surgery in patients on chronic dialysis.

Authors:  Amin Andalib; Ali Aminian; Zhamak Khorgami; Sankar D Navaneethan; Philip R Schauer; Stacy A Brethauer
Journal:  Surg Endosc       Date:  2015-09-28       Impact factor: 4.584

Review 9.  The effects of bariatric surgery on bone and nephrolithiasis.

Authors:  Khashayar Sakhaee; John Poindexter; Crystal Aguirre
Journal:  Bone       Date:  2015-12-08       Impact factor: 4.398

10.  Metabolic Syndrome and Nephrolithiasis Risk: Should the Medical Management of Nephrolithiasis Include the Treatment of Metabolic Syndrome?

Authors:  John Michael DiBianco; T W Jarrett; Patrick Mufarrij
Journal:  Rev Urol       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.